2. Search Result
Search Result
Results for "

factor+IX

" in MedChemExpress (MCE) Product Catalog:

12

Inhibitors & Agonists

3

Biochemical Assay Reagents

2

Peptides

4

Inhibitory Antibodies

3

Recombinant Proteins

1

Antibodies

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-145405
    C12-200
    15+ Cited Publications

    		 Liposome Others
    C12-200 is a type of ionizable cationic lipid and helper lipid commonly used for mRNA delivery. In the hemophilia B mouse model, mRNA encoding human erythropoietin (EPO) and coagulation factor IX (FIX) can be successfully delivered and expressed using C12-200. C12-200 is utilized in research related to hemophilia B .
    C12-200
  • HY-P9940
    Emicizumab

    ACE-910; RG6013

    		 Factor VIII Cardiovascular Disease
    Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research .
    Emicizumab
  • HY-E70541B
    Canine Factor IX

    		Biochemical Assay Reagents Cardiovascular Disease
    Canine Factor IX is a functional coagulation factor. Canine Factor IX shortens whole blood clotting time and activated partial thromboplastin time, and restores coagulation function. After intramuscular administration via rAAV vector in hemophilia B dogs, Canine Factor IX maintains a sustained circulating level for at least 1 year, partially corrects the hemophilia B phenotype in a dose-dependent manner, and its plasma expression persists for more than 17 months. Canine Factor IX is applicable to relevant research on hemophilia B .
    Canine Factor IX
  • HY-107966A
    Heparin calcium (MW 3600-5000)

    Nadroparin calcium (MW 3600-5000)

    		 Thrombin Factor Xa Autophagy Bacterial Cardiovascular Disease Cancer
    Heparin (Nadroparin) calcium (MW 3600-5000) is an anticoagulant which binds reversibly to antithrombin III (ATIII) to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin .
    Heparin calcium (MW 3600-5000)
  • HY-P4243A
    Dansyl-Glu-Gly-Arg-Chloromethylketone TFA

    		Ser/Thr Protease Others
    Dansyl-Glu-Gly-Arg-Chloromethylketone TFA is a protease inhibitor, and inhibits serine/threonine proteases. Dansyl-Glu-Gly-Arg-Chloromethylketone TFA inhibits activated porcine factor IX .
    Dansyl-Glu-Gly-Arg-Chloromethylketone TFA
  • HY-P4243
    Dansyl-Glu-Gly-Arg-Chloromethylketone

    		Ser/Thr Protease Others
    Dansyl-Glu-Gly-Arg-Chloromethylketone is a protease inhibitor, and inhibits serine/threonine proteases. Dansyl-Glu-Gly-Arg-Chloromethylketone inhibits activated porcine factor IX .
    Dansyl-Glu-Gly-Arg-Chloromethylketone
  • HY-E70541A
    Bovine Factor IX

    		Biochemical Assay Reagents Cardiovascular Disease
    Bovine Factor IX is prepared from freshly collected bovine plasma. Factor IX activated by the Factor VIIa/tissue factor/phospholipid complex is responsible for the activation of Factor X to Factor Xa .
    Bovine Factor IX
  • HY-107966
    Heparin calcium (MW 15000-19000)

    Nadroparin calcium (MW 15000-19000)

    		 Thrombin Factor Xa Autophagy Bacterial Cardiovascular Disease Cancer
    Heparin calcium (MW 15000-19000) is an anticoagulant which binds reversibly to antithrombin III (ATIII) to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin .
    Heparin calcium (MW 15000-19000)
  • HY-112935
    Nonacog alfa

    BAX326; Coagulation Factor IX [Recombinant]; BeneFIX

    		 Ser/Thr Protease Others
    Nonacog alfa (BAX326) is a recombinant human factor IX that can be used for the research of haemophilia B .
    Nonacog alfa
  • HY-P991213
    Nonacog gamma

    Rixubis

    		 Factor XI Cardiovascular Disease
    Nonacog gamma is a coagulation factor IX (FIX) supplement. Nonacog gamma activates coagulation factor X (FX), promotes the generation of thrombin, and then converts fibrinogen into fibrin, forming a stable blood clot to exert hemostatic activity. Nonacog gamma is promising for research of hemophilia B .
    Nonacog gamma
  • HY-P9940A
    Emicizumab (Anti-F9 & Factor IX)

    		Factor VIII Cardiovascular Disease
    Emicizumab (Anti-F9 & Factor IX) is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab (Anti-F9 & Factor IX) can be used for hemophilia A research .
    Emicizumab (Anti-F9 & Factor IX)
  • HY-E70393J
    Bovine Factor XIa

    		Factor XI Others
    Bovine Factor XIa is an enzyme, which is involved in the intrinsic pathway of blood coagulation. Bovine Factor XIa is highly selective and exhibits a minimal extended substrate recognition site of at least five residues long. Bovine Factor XIa is reactive as Bovine Factor IXa (HY-E70393I) does, that it cleaves all the peptides bearing factor IX activation site sequences .
    Bovine Factor XIa

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: